https://www.renaissancecapital.com/IPO-Center/News/103151/Brain-cancer-biotech-NeOnc-Technologies-sets-terms-for-$75-million-IPO
Brain cancer biotech NeOnc Technologies sets terms for $75 million IPO
This should give us a little idea of how undervalued we are.
The Westlake Village, CA-based company plans to raise $75 million by offering 3.8 million shares at a price range of $18.75 to $20.75. At the midpoint of the proposed range, NeOnc Technologies Holdings would command a fully diluted market value of $466 million.
NeOnc has 2 therapy candidates:
- NEO100, is a purified form of perillyl acid which is administered to brain cancer patients via intranasal delivery. The company is currently conducting a Phase 2a trial of NEO100 in recurrent malignant glioma patients, as well as a similar Phase 2a trial in patients with malignant skull-based meningioma. It expects a readout for its Phase 2 studies of NEO100 by the end of 2024.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7879254/
- NEO212, is a covalently conjugated molecule combining the chemotherapeutic drug temozolomide with perillyl alcohol. NEO212 has completed preclinical testing, and in the 4Q23, it entered a Phase 1/2 trial as an oral therapy in patients with primary and secondary brain tumors.
- Forums
- ASX - By Stock
- Ann: New data for Phase 1A CLTX CAR T brain cancer clinical trial
https://www.renaissancecapital.com/IPO-Center/News/103151/Brain-c...
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CHM (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $23.12M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 16965 | 2.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.7¢ | 16868 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 16965 | 0.028 |
6 | 1378548 | 0.027 |
7 | 779615 | 0.026 |
6 | 910000 | 0.025 |
10 | 1506666 | 0.024 |
Price($) | Vol. | No. |
---|---|---|
0.027 | 16868 | 1 |
0.028 | 158093 | 2 |
0.029 | 25624 | 1 |
0.030 | 221388 | 3 |
0.031 | 451071 | 4 |
Last trade - 09.18am 07/05/2024 (20 minute delay) ? |
Featured News
CHM (ASX) Chart |
Day chart unavailable
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
Previous Video
Next Video
SPONSORED BY The Market Online